# Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

> **NCT00984516** · PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 102 (actual)

## Conditions studied

- Cicatrix
- Wound-healing

## Interventions

- **DRUG:** Juvidex
- **DRUG:** Juvidex
- **DRUG:** Juvidex
- **DRUG:** Juvidex
- **DRUG:** Juvidex
- **DRUG:** Juvidex
- **DRUG:** Placebo
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00984516
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2009-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984516, "Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00984516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*